The induction of activating transcription factor 3 (ATF3) contributes to anti-cancer activity of Abeliophyllum distichum Nakai in human colorectal cancer cells
Open Access
- 15 December 2014
- journal article
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 14 (1) , 487
Abstract
Recently, Abeliophyllum distichum Nakai (A. distichum) has been reported to exert the inhibitory effect on angiotensin converting enzyme. However, no specific pharmacological effects from A. distichum have been described. We performed in vitro study to evaluate anti-cancer properties of A. distichum and then elucidate the potential mechanisms.Keywords
This publication has 26 references indexed in Scilit:
- Activation of the Canonical Wnt/β-Catenin Pathway in ATF3-Induced Mammary TumorsPLOS ONE, 2011
- MDM2 Mediates Ubiquitination and Degradation of Activating Transcription Factor 3Journal of Biological Chemistry, 2010
- Activating transcription factor 2 (ATF2) controls tolfenamic acid-induced ATF3 expression via MAP kinase pathwaysOncogene, 2010
- AM251 suppresses the viability of HepG2 cells through the AMPK (AMP-activated protein kinase)–JNK (c-Jun N-terminal kinase)–ATF3 (activating transcription factor 3) pathwayBiochemical and Biophysical Research Communications, 2008
- Green tea catechin (−)-epicatechin gallate induces tumour suppressor protein ATF3 via EGR-1 activationEuropean Journal of Cancer, 2007
- Indole-3-carbinol and 3,3′-diindolylmethane induce expression of NAG-1 in a p53-independent mannerBiochemical and Biophysical Research Communications, 2005
- Four glycosides from the leaves of Abeliophyllum distichum with inhibitory effects on angiotensin converting enzymePhytotherapy Research, 2003
- Molecular Mechanism of Transcriptional Repression of Gelsolin in Human Breast Cancer CellsExperimental Cell Research, 2002
- The Transcriptional Program in the Response of Human Fibroblasts to SerumScience, 1999
- ATF3 GeneJournal of Biological Chemistry, 1996